The Salt Cave

Structure and Characteristics of the Salt Cave

The floor, the walls, and the ceiling of the salt cave are covered with food grade fine crystal salt. 
Tons of large salt rocks surround the visitors placed along the walls and also displayed in wooden 
crates. This salt is dry and clean. To ensure the purest quality, we use Himalayan pink crystal salt. 
The size of the room is 450 sq. feet which allows 8+ persons to comfortably be seated during the 
Halotherapy sessions. Children have a dedicated area to play in order not to disturb the others. The 
salt cave itself is a completely separate space, isolated from the rest of our store areas.

Inside the salt cave, visitors can experience the following conditions:

*    humidity of 40-50%
*    temperature of 70-75 F
*    the aerosol concentration of 0,5-15 mg/m3

The salt aerosol consists of salt particles in sizes of 1-5 micrometers. The particles carry
kinetic energy which is succeeding immediately after crushing the salt crystals in the grinder.

The salt concentration of the air in the treatment area is approximately 73.5 mg (0.0002592 oz) - 
similar to the consistency of salty air at the beach on an average morning. But the salt consistency 
can be adjusted: in case of different diseases, various cure modes can be implemented.

The salt cave prefigures a dry, sterile and hermetic space. The large amount of dry rock salt 
creates a special microclimate which is identical to the underground salt caves.

The visitors sit in relaxed positions on comfortable lounge chairs during the sessions. Calming 
music is added to help them relax. The aerosol emerging from the salt generator is beneficial for 
various health conditions. Click here to read about the benefits of halotherapy.

The session lasts 45 minutes.

Please read the Policies and Guidelines of the Salt Cave


The Salt Generator

The salt generator produces dry salt aerosol in a non-stop regime, which guarantees maximum 
healing intensity and effectiveness. It also provides options to adjust the treatment regime in the salt 
room according to specific patient's needs. For example:

•    Various sizes of salt particles.
•    Levels of energy carried by these particles.
•    Concentration of the aerosol.
•    Duration of treatment.

To ensure excellent quality and performance, we use an Iiris automatic digital generator which is 
characterized with the following data:

•    Size of the generator is: 50cm/1.70’ (height), 40cm/15.75’  (width), 25cm/9.85’ (depth).
•    Weight 21kg/46lbs
•    Circumvolution of the crushing of salt is 8,000 – 25,000 rpm
•    Intensity of aerosol coming from the generator to the salt room varies from 10% to 100%
•    Intensity of raw salt coming from feeder to crushing instrument is 0.1 to 5.0 g/min
•    Time for salt room ventilation before the sessions is approximately 15 min
•    Voltage inside the generator is 12V
•    Possible outside voltages are 230V, 90V and 110V
•    Maximum power consumption of the generator is 100 W
•    Automatic power switch-overs of lighting and ventilation do not exceed 1500W

Iris salt aerosol generators are certified for electrical safety by CSA (Canadian Standard 
Association).

Our Iiris generator's GMDN*code number 12712, is registered by:

• Estonian State Agency of Medicine reference number INDT-INDI-7365.
• Estonian Patent Office. Models: EE 00430 U1, 12.11.2003; EE2004/000008, 07.12.2004; 
  EE 00431 U1, 09.12.2003; EE 00524 U1, 08.03.2005; D200700042, 22.05.2007; 
  U200700059, 23.05.2007.
• Estonian Electrical Inspection Centre reference number 9-5/90.
• EC European Community electrical safety certification reference number EVS-EN 60204.
• GMDN - The Global Medical Device Nomenclature

The Global Medical Device Nomenclature (GMDN) provides the use of generic descriptors for the 
identification of medical devices and other Healthcare related products.
Medical Device experts from around the world (manufacturers, healthcare authorities and 
regulators) comply with the GMDN requirements based on the standard ISO 15225. GMDN work 
was mandated by the European Commission in order to provide the necessary tool to carry out 
many of the obligations following the implementation of the Medical Devices Directives, as well as 
to meet similar needs at the Global level as identified in the Global harmonization activities of 
GHTF by its members, notably USA (FDA), Canada, European member states, Japan, Australia 
and now by many other countries/regions.